대한암한의학회지 (Journal of Korean Traditional Oncology)

  • 제27권1호
  • /
  • Pages.25-36
  • /
  • 2022
  • /
  • 1975-244X(pISSN)
  • /
  • 2765-4850(eISSN)
대한암한의학회 (Korean Association of Traditional Oncology)
권호 표지
DOI QR코드

DOI QR Code

한의 종양학 연구 분야에서의 Propensity Score Matching Method 적용에 대한 문헌 고찰

A Literature Review on the Application of the Propensity Score Matching Method in the Field of Asian Oncology

  • 김동현 (대전대학교 한방내과학교실) ;
  • 김종희 (대전대학교 한방내과학교실) ;
  • 유화승 (대전대학교 서울한방병원 동서암센터) ;
  • 박소정 (부산대학교 한의학전문대학원, 부산대학교 한방병원)
  • Dong-hyeon, Kim (Korean Medicine Class, Daejeon National University) ;
  • Jong-hee, Kim (Korean Medicine Class, Daejeon National University) ;
  • Hwa-seung, Yoo (East-West Cancer Center, Seoul Korean Medicine Hospital of Daejeon National University) ;
  • So-jung, Park (Pusan Korean Medicine Hospital, Korean Medicine Graduate School of Pusan National University)
  • 투고 : 2022.10.19
  • 심사 : 2022.12.14
  • 발행 : 2022.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The Randomized Control Trial (RCT) is the most well-established and widely used statistical methodology in clinical research; however, applying thorough RCT to cancer patients presents challenges such as ethical concerns, high costs, short clinical periods, and limitations in collecting various side effects. To address this issue, the propensity score matching method, which takes advantage of the benefits of observational research while compensating for the drawbacks of randomized control trials, is used in a variety of fields. In recent years, 28 studies on the effectiveness of Korean medicine on tumors have been conducted abroad using the Propensity Score Matching Method, but none have been conducted in Korea. The majority of studies have focused on liver cancer, colon cancer, lung cancer, and stomach cancer, with endpoints such as survival time, incidence rate, quality of life, and treatment outcomes revealing statistical differences in how Korean medicine intervention affects treatment outcomes. As a result, well-established studies using the propensity matching score methodology should be useful in evaluating the impact of Korean medicine in oncology treatments.

키워드

과제정보

본 연구는 2022년도 부산대학교병원 임상연구비 지원으로 이루어졌습니다.

참고문헌

  1. Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148.  https://doi.org/10.17085/apm.2016.11.2.130
  2. Luellen JK, Shadish WR, Clark MH. Propensity scores: an introduction and experimental test. Eval Rev 2005; 29: 530-58.  https://doi.org/10.1177/0193841X05275596
  3. Hooker, Andrew C., Mats O. Karlsson, Justin J. Wilkins, and E. Niclas Jonsson. 2020. Xpose4: Diagnostics for Nonlinear Mixed-Effect Models. 
  4. Day AG. Why the propensity for propensity scores? Crit Care Med 2015; 43:2024-6.  https://doi.org/10.1097/CCM.0000000000001175
  5. Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015).  https://doi.org/10.1007/s12103-014-9269-z
  6. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv 2008; 22:31-72.  https://doi.org/10.1111/j.1467-6419.2007.00527.x
  7. 백영민, 박인서, 「R기반 성향점수분석: 루빈 인과모혈 기반 인과추론」, 한나래 아카데미, 2021 
  8. Dong Kyu Lee, An introduction to propensity score matching methods. Anesth Pain Med 2016; 11:130-148.  https://doi.org/10.17085/apm.2016.11.2.130
  9. Shi, Qi, et al. "Exploring the medication duration based on the effect of traditional Chinese medicine on postoperative stage I-III colorectal patients: a retrospective cohort study." Oncotarget 8.8 (2017): 13488. 
  10. Chiu, Sheng-Chun, et al. "Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells." BMC complementary and alternative medicine 17.1 (2017): 1-12.  https://doi.org/10.1186/s12906-016-1505-2
  11. Tsai, Yueh-Ting, et al. "Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer." Medicine 96.35 (2017). 
  12. Ren, Xuejiao, et al. "Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma." Radiotherapy and Oncology 129.2 (2018): 293-299.  https://doi.org/10.1016/j.radonc.2018.09.006
  13. Chen, Chin-Nu, Yueh-Ting Tsai, and Jung-Nien Lai. "8 years post-marketing surveillance between Asari Radix and hepatocellular carcinoma: Nationwide population-based evidence against an association." Journal of ethnopharmacology 243 (2019): 112094. 
  14. Xie, Gang, et al. "Aidi injection, a traditional Chinese medicine injection, could be used as an adjuvant drug to improve quality of life of cancer patients receiving chemotherapy: a propensity score matching analysis." Integrative cancer therapies 18 (2019): 1534735418810799. 
  15. Liu, Chien-Ting, et al. "Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study." Trials 20.1 (2019): 1-8.  https://doi.org/10.1186/s13063-018-3101-x
  16. Chang, Chia-Chen, et al. "Conventional Western treatment associated with Chinese herbal medicine ameliorates the incidence of head and neck cancer among patients with esophageal cancer." Integrative cancer therapies 18 (2019): 1534735419834353. 
  17. Liu, Yao, et al. "Fufang Banmao Capsule, a Traditional Chinese Medicinal Formulation, Enhances the Survival of Patients with Hepatocellular Carcinoma and Vp3-4 Portal Vein Tumor Thrombosis Undergoing Supportive Treatment." The Journal of Alternative and Complementary Medicine 26.10 (2020): 956-965.  https://doi.org/10.1089/acm.2019.0334
  18. Lin, Tsai-Hui, et al. "Conventional western treatment combined with Chinese herbal medicine alleviates the progressive risk of lung cancer in patients with chronic obstructive pulmonary disease: A nationwide retrospective cohort study." Frontiers in pharmacology 10 (2019): 987. 
  19. Chen, Hsing-Yu, et al. "Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study." BMC complementary and alternative medicine 19.1 (2019): 1-13.  https://doi.org/10.1186/s12906-018-2420-5
  20. Su-Tong, Liu, et al. "The effect of long-term traditional Chinese medicine treatment on disease-free survival of postoperative stage I-III lung cancer patients: a retrospective cohort study." Traditional Medicine Research 4.2 (2019): 91. 
  21. Shi, Ke, et al. "Adjuvant Fuzheng Huayu capsule reduces the incidence of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis." Evidence-Based Complementary and Alternative Medicine 2020 (2020). 
  22. Huang, Chia-Yu, et al. "Chinese herbal medicine is helpful for survival improvement in patients with multiple myeloma in Taiwan: A nationwide retrospective matched-cohort study." Integrative Cancer Therapies 19 (2020): 1534735420943280. 
  23. Zhao, He-tong, et al. "Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study." Journal of Integrative Medicine 18.4 (2020): 319-325.  https://doi.org/10.1016/j.joim.2020.05.003
  24. Zhang, Zhen, et al. "Data Mining and System Pharmacology to Elucidate the Efficiency and Mechanism of Chinese Medicine in Treating Primary Liver Cancer." (2020). 
  25. Liao, Yu-Pei, et al. "Effects and relative factors of adjunctive Chinese medicine therapy on survival of hepatocellular carcinoma patients: a retrospective cohort study in taiwan." Integrative Cancer Therapies 19 (2020): 1534735420915275. 
  26. Wang, Yuli, et al. "The effect of long-term traditional Chinese medicine treatment on survival time of colorectal cancer based on propensity score matching: a retrospective cohort study." Evidence-Based Complementary and Alternative Medicine 2020 (2020). 
  27. Shi, Qi, et al. "A Four Ingredients Chinese Herbal Formula, Decreases the Metastatic Recurrence of Postoperative Patients With Stage II-III Colorectal Cancer." (2021). 
  28. Hou, Chao, et al. "Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study." Integrative cancer therapies 20 (2021): 15347354211058464. 
  29. Xu, Li-Li, et al. "The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching." Evidence-Based Complementary and Alternative Medicine 2021 (2021). 
  30. Shih, Wei-Tai, et al. "Traditional Chinese medicine enhances survival in patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: a nationwide matched cohort study." Evidence-Based Complementary and Alternative Medicine (2021). 
  31. Yang, Shu-Yi, et al. "Association of Chinese herbal medicine use with the depression risk among the long-term breast cancer survivors: A longitudinal follow-up study." Frontiers in Psychology (2022). 
  32. Tan, Ying, et al. "Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response." Frontiers in pharmacology 13 (2022). 
  33. Hou, Zong, et al. "Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer." Journal of Ethnopharmacology 292 (2022): 115222. 
  34. Hou, Jie, et al. "Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer." Evidence-Based Complementary and Alternative Medicine 2022 (2022). 
  35. Luo, Shaoju, and Hao Hu. "Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysis." Journal of Ethnopharmacology (2022): 115774. 
  36. Li, Honglin, et al. "Traditional Chinese Medicine Decoctions Improve Longevity Following Diagnosis with Stage IV Esophageal Squamous Cell Carcinoma: A Retrospective Analysis." International Journal of General Medicine 15 (2022): 1665. 
  37. Tusty ten Bensel, Benjamin Gibbs & Robert Lytle. A Propensity Score Approach towards Assessing Neighborhood Risk of Parole Revocation. American Journal of Criminal Justice volume 40, pages377-398 (2015).  https://doi.org/10.1007/s12103-014-9269-z
  38. King, Gary, and Richard Nielsen. "Why propensity scores should not be used for matching: Supplementary appendix." (2016). 
  39. 박봉기, et al. "국내에 보고된 한국 한의학의 암치료 임상연구에 대한 계통적 고찰." 대한한방내과학회지 29.4 (2008): 1061-1074.